Application 076850
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TERCONAZOLE | TERCONAZOLE | SUPPOSITORY;VAGINAL | 80MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076850-001 | TERCONAZOLE | TERCONAZOLE | 80MG | SUPPOSITORY / VAGINAL | 2006-07-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076850-001 | TERCONAZOLE | 80MG | SUPPOSITORY / VAGINAL | 2006-07-12 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terconazole | TERCONAZOLE | Cosette Pharmaceuticals, Inc. | 38cd1718-6b3c-415d-a17f-7b399adb0ba2 | 2026-05-07 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole Vaginal Cream 0.8% | TERCONAZOLE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | f59448bd-f730-46d2-a785-c2d6205579ff | 2026-01-28 | Warnings, Adverse reactions | TERCONAZOLE |
| Terconazole | TERCONAZOLE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 10e84353-93d2-461d-8b79-e9294df047ae | 2026-01-28 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | 6d7a8fd6-7837-427e-9b18-89e33351b05e | 2025-07-07 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | b4f50a11-bd39-4023-9145-2da60f6b085f | 2025-07-07 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | 2b3923b5-0a97-428c-b8d2-4a3ceb3447a1 | 2025-05-27 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | NuCare Pharmaceuticals,Inc. | 71c13149-396e-edc6-e053-2a95a90af50c | 2024-12-24 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | Padagis Israel Pharmaceuticals Ltd | 207e9cf2-e8ec-43d7-9c11-46283c9cdb37 | 2024-09-30 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | b922feb5-cd85-4f13-9a18-913e58f8da83 | 2023-12-09 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | e0a5e163-741f-4f5e-9d2e-b733f9879c99 | 2023-10-31 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |
| Terconazole Vaginal Cream 0.8% | TERCONAZOLE | A-S Medication Solutions | 9b1c38ac-ebf3-471c-bcdf-1ff8ad197f91 | 2023-01-03 | Warnings, Adverse reactions | TERCONAZOLE |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | 1e32bf0d-2a93-44ac-ae28-8d34e10380c0 | 2023-01-03 | Warnings, Adverse reactions | Terconazole TERCONAZOLE |